Clinical trial
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
NCT01938248 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
- Lead sponsor
- Population Health Research Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- November 3, 2023
- Enrollment
- 4,012 (actual)
- Sites
- 130
Conditions
As the registry lists them; a condition with its own page is linked.